DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 117 filers reported holding DYNE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $315,804 | -22.7% | 35,246 | -2.9% | 0.00% | – |
| Q2 2023 | $408,555 | +506.5% | 36,316 | +521.1% | 0.00% | – |
| Q1 2023 | $67,358 | +6635.8% | 5,847 | +14161.0% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 41 | -88.5% | 0.00% | – |
| Q2 2022 | $2,000 | -84.6% | 356 | -74.1% | 0.00% | – |
| Q1 2022 | $13,000 | -91.0% | 1,373 | -88.6% | 0.00% | – |
| Q4 2021 | $144,000 | +1957.1% | 12,045 | +3629.1% | 0.00% | – |
| Q2 2021 | $7,000 | -91.0% | 323 | -93.6% | 0.00% | – |
| Q1 2021 | $78,000 | -49.7% | 5,049 | -31.7% | 0.00% | – |
| Q4 2020 | $155,000 | – | 7,389 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,220,034 | $25,730,194 | 34.58% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $57,385,602 | 24.01% |
| Atlas Venture Life Science Advisors, LLC | 9,869,483 | $114,387,308 | 13.78% |
| Logos Global Management LP | 2,150,000 | $24,918,500 | 2.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 641,068 | $7,417,157 | 2.29% |
| Deep Track Capital, LP | 2,684,200 | $31,109,878 | 1.31% |
| EcoR1 Capital, LLC | 2,322,384 | $26,916,431 | 0.82% |
| Vivo Capital, LLC | 577,642 | $6,695 | 0.77% |
| HighVista Strategies LLC | 102,431 | $1,187,175 | 0.70% |
| Monashee Investment Management LLC | 123,719 | $1,433,903 | 0.62% |